site:www.pharmabiz.com

News

Relief Therapeutics’ RLF-TD011 receives US FDA rare paediatric disease designation for treatment of epidermolysis bullosa

Geneva, Switzerland Saturday, May 24, 2025, 15:30 Hrs [IST] ...

Pharmabiz21h

OSE Immunotherapeutics partners with Inside Therapeutics & MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development

OSE Immunotherapeutics partners with Inside Therapeutics & MiNT Laboratory to develop mRNA therapeutics and accelerate nanodrug development: Nantes, France Saturday, May 24, 2025, ...

Pharmabiz20h

PacBio appoints Haorui Gen to expand distribution in China and to gain access to new clinical laboratory networks

Menlo Park, California Saturday, May 24, 2025, 16:30 Hrs [IST] ...

Pharmabiz22h

Predictive Oncology breakthrough coincides with Regeneron Pharma’s acquisition of 23andMe for $256 million: Artificial intelligence meets genomics

Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

Pharmabiz23h

Bayer launches Centafore, an imaging core lab service to support clinical trials and software as a medical device development

Whippany, New Jersey Saturday, May 24, 2025, 14:00 Hrs [IST] ...

Pharmabiz22h

Medicus Pharma receives UAE Department of Health approval to start phase 2 trial of SKNJCT-004 to treat basal cell carcinoma of skin

Philadelphia, Pennsylvania Saturday, May 24, 2025, 14:30 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results